Creatine and Kidney Safety: What the Long-Term Data Actually Shows

Creatine's kidney safety question comes up more than almost anything else about the ingredient, and there's a real mechanistic reason for the worry — even though it's not the reason most people think. The short version: creatine supplementation raises a number on a routine blood panel that doctors use to screen for kidney disease. The longer, more useful version is why that number moves, what happens to actual kidney function when it's measured properly, and where the real caution lines are.

Where the concern actually comes from

Creatine supplementation raises serum creatinine, and serum creatinine is also the standard blood marker doctors use to estimate kidney function (eGFR). On the surface, that looks like a red flag. But creatinine rises with creatine supplementation because of increased creatine-to-creatinine metabolic turnover in muscle, not because the kidneys are being damaged — the marker moves for a reason unrelated to renal injury, which is exactly why relying on serum creatinine alone to judge creatine's kidney safety is misleading.

This is a known limitation of creatinine-based eGFR in general, not something unique to supplement users. Anyone with more muscle mass than average — bodybuilders, athletes, people who just started lifting seriously — tends to run a slightly higher serum creatinine and a slightly lower creatinine-based eGFR, without any actual reduction in how much blood their kidneys filter. Creatine supplementation adds to that same effect. The question that actually matters isn't "does creatinine go up" — it's "does the kidney's actual filtration capacity go down." Those are two different questions, and only trials that measure filtration by a method independent of creatinine can answer the second one. It's worth adding that a blood panel is not the only thing worth checking on any supplement: what a certificate of analysis actually tells you covers what's in the tub in the first place.

What the trial data in healthy adults shows

A 2025 systematic review and meta-analysis in BMC Nephrology pooled the RCT evidence directly: 21 studies in the systematic review, 12 of them entered into the meta-analysis of serum creatinine (177 participants on creatine, 263 controls), spanning supplementation periods from under a week up to more than 12 weeks.¹ The result: a small but statistically significant rise in serum creatinine (mean difference 0.07 µmol/L, 95% CI 0.01 to 0.12, p=0.03) — and no statistically significant difference in glomerular filtration rate.

The timing pattern is more interesting than a flat "creatinine goes up." Broken down by follow-up duration, the increase was significant in studies lasting a week or less (MD 0.12, 95% CI 0.03 to 0.21), not significant between one and twelve weeks (MD 0.04, 95% CI −0.09 to 0.17), and significant again beyond twelve weeks. The authors' own characterisation is a "modest, transient increase in serum creatinine levels, likely due to metabolic turnover rather than renal impairment." Note also what GFR meant in most of these trials: an estimate, usually derived from creatinine or cystatin C, not a reference-standard clearance measurement. That's why the second analysis below matters more for this specific question.

The 2026 meta-analysis: why the method you measure with changes the answer

A larger systematic review and meta-analysis published in International Urology and Nephrology in 2026 makes the creatinine-vs-function distinction explicit, and it's the clearest evidence yet on why this confusion persists.² Pooling 26 RCTs and 1,036 participants across both healthy adults and people with chronic kidney disease, the review confirmed the now-familiar pattern: serum creatinine rose by a small but statistically significant amount (mean difference 0.14 mg/dL, 95% CI 0.05 to 0.22, P=.002) — though with very high heterogeneity between studies (I²=93.9%), which is a real limit on how precisely that figure should be read. When GFR was estimated using creatinine-based formulas, that same rise showed up as an apparent drop in kidney function (mean difference −10.75 mL/min, 95% CI −17.48 to −4.02, P=.002, I²=0%) — which is exactly the kind of number that fuels the "creatine hurts your kidneys" narrative.

But when GFR was measured with Cr-EDTA clearance — a reference-standard method that doesn't depend on creatinine at all — there was no significant change (mean difference +5.89 mL/min, 95% CI −0.30 to 12.08, P=.06, confidence interval crossing zero). Serum urea, proteinuria, albuminuria and urinary creatinine also showed no significant differences between creatine and placebo groups. In plain terms: the "kidney damage" only shows up when you measure kidney function with the same molecule creatine is busy raising. Measure it independently, and the effect disappears. Two honest caveats: the Cr-EDTA result is a non-significant finding, which is not the same as proof of no effect, and in the hemodialysis subgroup specifically creatine was associated with a significant rise in serum creatinine while serum urea fell significantly. The authors' conclusion is that these findings likely reflect altered creatinine metabolism rather than kidney injury.

Measured with a reference-standard method that doesn't depend on creatinine, kidney filtration didn't significantly change — the "decline" only appears when the measuring stick is the same molecule creatine raises.

What about people with existing kidney disease?

This is the caveat that matters, and it's worth being direct about how thin the evidence still is. Most of the trial data above comes from healthy or generally healthy adults — the population creatine is actually marketed to and used by. Long-term, high-quality RCT evidence in people who already have reduced kidney function is much sparser.

The most relevant new data point here is a small open-label pilot study in hemodialysis patients, published in PLOS ONE in 2025.³ Eighteen patients on long-term dialysis (average dialysis duration over five years, most with hypertension and diabetes) took 5g of creatine monohydrate daily for 8 weeks. Physical function scores, skeletal muscle mass, and phase angle (a marker of cellular health) all improved, and dialysis adequacy stayed stable with no adverse effects reported. That's a genuinely encouraging early signal for a population that loses muscle mass at a high rate — but it's one small, open-label pilot with no placebo arm and no blinding, not a controlled trial powered to detect rare harms, and it doesn't generalize to earlier-stage CKD that isn't yet on dialysis. The 2026 meta-analysis above is more reassuring on filtration markers specifically, but its own authors flagged that more trials in advanced CKD populations are still needed.

If you have any diagnosed kidney condition — from early-stage CKD to dialysis dependence — this is a conversation with your nephrologist or physician before you supplement, not a decision to make from a blog post. The evidence so far doesn't suggest creatine is dangerous in this population, but "doesn't suggest danger" and "is well-established as safe" are different standards, and this population deserves the higher one.

It's also worth noting what these trials are not measuring: none of them are testing creatine as a treatment for kidney disease, and nobody should read it that way. The interest in dialysis and CKD populations is about muscle wasting — a well-documented complication of reduced kidney function — not about creatine improving renal outcomes themselves. Those are separate questions, and conflating them would be exactly the kind of overreach this evidence doesn't support.

Bottom line

In healthy adults, the RCT evidence doesn't support the "creatine damages your kidneys" concern — the creatinine rise is a measurement artifact of how creatine is metabolized, modest and transient, and filtration markers stay flat across the studied durations, including when measured by reference-standard Cr-EDTA clearance in the largest pooled analysis available. The caveat that matters is pre-existing kidney disease, where the evidence base is smaller, more preliminary, and not a substitute for a conversation with your own doctor. For the other safety questions people ask most, see bloating and water retention, whether creatine dehydrates you and the hair-loss question; on protocol, whether you need a loading phase and how much you need if cognition is the goal.

This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Speak with a healthcare provider before starting any new supplement, especially if you take medication or have an existing health condition.

References

1. Naeini EK, Eskandari M, Mortazavi M, Gholaminejad A, Karevan N. Effect of creatine supplementation on kidney function: a systematic review and meta-analysis. BMC Nephrology, 2025;26:622. pubmed.ncbi.nlm.nih.gov
2. de Souza Almeida A, da Silva LOD, Takahasi BNA, et al. Impact of creatine supplementation on kidney health: a systematic review and meta-analysis. International Urology and Nephrology, 2026. link.springer.com
3. Oral creatine in hemodialysis patients increases physical functional capacity and muscle mass, an open label study. PLOS ONE, 2025. journals.plos.org

Related reading: Creatine Monohydrate: The Complete Guide, Creatine and the Brain and Creatine Timing: Does Pre vs Post-Workout Actually Matter?.

Creatine is no longer part of the Proco range. If focus and cognitive performance is what you're after, Cognitive Support is the closest fit in our current lineup. Shop Cognitive Support →